Another druggie company I have been watching. I believe Surfaxin is the drugs name.
They have been gonged twice by the FDA but the issue appears to be more manufacturing in scope instead clinical in nature. That can get resolved.
This morning they received a 60 million infusion of cash over the next 3 years from Kingsbridge Capital. They evidently think the issues will get resolved! Solves any money issue for launching this if the FDA accepts the manufacturing fixes.
Its up nicely percentagewise in the pre-market.
Now I am watching them closely for some potential investment. The PPS is compelling for an ACOR kind of move-will it happen?
Heh its a baby drug company! I just don't know for sure?
Lke the ticker symbol though-Macho Macho man............ I want to be.........!